Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

123.12
Delayed Data
As of May 22
 +1.19 / +0.98%
Today’s Change
13.09
Today|||52-Week Range
154.75
+34.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization8.0K9.0K60.0K23.0K
 
 
 
 
 
 
Operating ExpensesGross Income-8.0K-9.0K-60.0K-23.0K
 
 
 
 
 
General Expenses8.4M8.6M8.9M7.0M
 
 
 
 
 
Research And Development6.8M6.7M6.5M5.2M
 
 
 
 
 
Total Operating Expenses8.4M8.6M8.9M7.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.4M-8.6M-8.9M-7.1M
 
 
 
 
 
Other Expenses0.00100.0K250.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.3M-8.4M-8.4M-6.4M
 
 
 
 
 
Net Income-8.3M-8.4M-8.4M-6.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.0M12.4M12.6M14.1M
 
 
 
 
 
Shares To Calculate EPS Diluted12.0M12.4M12.6M14.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.69-$0.68-$0.67-$0.45
 
 
 
 
 
EPS Diluted-$0.69-$0.68-$0.67-$0.45